| Literature DB >> 30018603 |
Anna Freixa1, Vicenç Acuña1, Marina Gutierrez1, Josep Sanchís2, Lúcia H M L M Santos1, Sara Rodriguez-Mozaz1, Marinella Farré2, Damià Barceló1,2, Sergi Sabater1,3.
Abstract
Organic micro-contaminants (OMCs) enter in freshwaters and interact with other contaminants such as carbon nanoparticles, becoming a problem of unknown consequences for river ecosystems. Carbon nanoparticles (as fullerenes C60) are good adsorbents of organic contaminants and their interaction can potentially affect their toxicity to river biofilms. We tested the C60 interactions with selected OMCs and their effects on river biofilms in different short-term experiments. In these, river biofilms were exposed to C60 and three OMCs (triclosan, diuron, or venlafaxine) and their respective mixtures with fullerenes (C60 + each OMC). The effects were evaluated on structural, molecular, and functional descriptors of river biofilms. Our results showed that C60 did not cause toxic effects in river biofilms, whereas diuron and triclosan significantly affected the heterotrophic and phototrophic components of biofilms and venlafaxine affected only the phototrophic component. The joint exposure of C60 with venlafaxine was not producing differences with respect to the former response of the toxicant, but the overall response was antagonistic (i.e., decreased toxicity) with diuron, and synergistic (i.e., increased toxicity) with triclosan. We suggest that differences in the toxic responses could be related to the respective molecular structure of each OMC, to the concentration proportion between OMC and C60, and to the possible competition between C60 pollutants on blocking the receptors of the biological cell membranes. We conclude that the presence of C60 at low concentrations modified the toxicity of OMC to river biofilms. These interactions should therefore be considered when predicting toxicity of OMC in river ecosystems.Entities:
Keywords: carbon nanoparticles; diuron; microbial ecotoxicology; mixtures; periphyton; pollutants; triclosan; venlafaxine
Year: 2018 PMID: 30018603 PMCID: PMC6037823 DOI: 10.3389/fmicb.2018.01426
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Chemical and toxic characteristics of the organic micro-contaminants used in this experiment.
| Compound | Formula | Molar mass (g/mol) | Log kow∗ | Log D8∗ | Major species at pH 8 | pKa | EC50 | |
|---|---|---|---|---|---|---|---|---|
| Venlafaxine | Psychiatric drug | C17H27NO2 | 277.40 | 2.74 | 1.78 | Cation | 10.09 | EC50 72 h algae = 11,000 μg L−1 ( |
| Triclosan | Antibacterial | C12H7O2Cl3 | 289.54 | 4.98 | 4.50 | Anion | 7.9 | EC50 48 h bacteria = 43.8 μg L−1 ( |
| Diuron | Herbicide | C9H10Cl2N2O | 233.09 | 2.53 | 2.53 | Neutra | 13.18 | EC50 24 h algae = 13.3 μg L−1 ( |
Nutrients and DOC concentrations for each treatment and experiment (1; venlafaxine, 2; diuron, 3; triclosan).
| DOC mgL−1 | N-NO2 μgL−1 | N- | N- | P- | ||
|---|---|---|---|---|---|---|
| Experiment 1 | Control | 2.62 ± 0.18 | 18.55 ± 1.03 | 1.58 ± 0.07 | 3.87 ± 0.01 | 3.75 ± 0.01 |
| C60 | 2.38 ± 0.25 | 16.76 ± 2.30 | 1.59 ± 0.03 | 3.87 ± 0.01 | 4.16 ± 1.38 | |
| VEN | 7.41 ± 0.27∗∗ | 23.86 ± 2.15∗∗ | 1.56 ± 0.11 | 3.76 ± 0.28 | 2.77 ± 0.01 | |
| VENC60 | 7.18 ± 0.43∗∗ | 24.46 ± 0.58∗∗ | 1.54 ± 0.09 | <LOQ | 3.75 ± 0.23 | |
| Experiment 2 | Control | 3.66 ± 0.37 | 22.41 ± 3.31 | 1.40 ± 0.09 | 4.13 ± 0.01 | <LOQ |
| C60 | 4.10 ± 0.54 | 28.77 ± 0.24∗ | 1.32 ± 0.09 | 3.53 ± 0.01∗ | 3.86 ± 0.90∗ | |
| DIU | 8.99 ± 1.07∗∗ | 29.07 ± 1.18∗ | 1.50 ± 0.03∗ | 7.28 ± 2.15 | 5.49 ± 1.97∗ | |
| DIUC60 | 7.76 ± 1.26∗ | 28.40 ± 2.62 | 1.67 ± 0.01 | <LOQ | 4.73 ± 0.01 | |
| Experiment 3 | Control | 3.63 ± 0.13 | 26.47 ± 5.58 | 1.32 ± 0.07 | 7.54 ± 2.53 | 5.60 ± 1.96 |
| C60 | 4.52 ± 1.65 | 27.60 ± 4.95 | 1.24 ± 0.10 | 3.94 ± 0.29 | 3.26 ± 0.01∗ | |
| TCS | 4.21 ± 0.18∗ | 28.21 ± 6.91 | 1.21 ± 0.02 | <LOQ∗∗ | 3.26 ± 0.12∗ | |
| TCSC60 | 4.23 ± 0.04∗∗ | 25.52 ± 7.66 | 1.31 ± 0.08 | <LOQ∗∗ | 3.75 ± 0.01 |
Fullerenes (C60) and organic micro-contaminants (OMCs) concentration, expressed as μg L−1, at time 0 h and after 72 h of exposure for each experiment (1; venlafaxine, 2; diuron, 3; triclosan) and treatments.
| C(C60) | C(OMC) | ||||
|---|---|---|---|---|---|
| Experiment 1 | Control | <LOD | <LOD | <LOD | <LOD |
| C60 | 3.08 ± 0.25 | 1.30 ± 0.07 | <LOD | <LOD | |
| VEN | <LOD | <LOD | 56.30 ± 2.13 | 51.01 ± 1.34∗ | |
| VENC60 | 3.02 ± 0.12 | 1.07 ± 0.04 | 49.90 ± 2.83 | 43.86 ± 1.01 | |
| Experiment 2 | Control | <LOD | <LOD | <LOD | <LOD |
| C60 | 2.50 ± 0.25 | 1.20 ± 0.39 | <LOD | <LOD | |
| DIU | <LOD | 0.002 ± 0.001 | 10.29 ± 0.25 | 8.95 ± 0.15∗∗ | |
| DIUC60 | 2.57 ± 0.04 | 1.04 ± 0.14 | 9.72 ± 0.33 | 9.31 ± 0.96 | |
| Experiment 3 | Control | <LOD | 0.016 ± 0.022 | <LOD | <LOD |
| C60 | 1.35 ± 0.03 | 0.30 ± 0.07∗ | <LOD | <LOD | |
| TCS | 0.018 ± 0.005 | 0.017 ± 0.025 | 8.24 ± 0.95 | 4.87 ± 0.17 | |
| TCSC60 | 1.25 ± 0.04 | 0.37 ± 0.04∗ | 6.80 ± 0.87 | 3.39 ± 0.30∗ | |
Results of the generalized linear model (GLM) for the analyzed endpoints for each experiment and treatment.
| Endpoints | Experiment 1 Venlafaxine | Experiment 2 Diuron | Experiment 3 Triclosan | ||||||
|---|---|---|---|---|---|---|---|---|---|
| C60 | VEN | VENC60 | C60 | DIU | DIUC60 | C60 | TCS | TCSC60 | |
| Chl- | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| EPS | ns | ns | ns | ns | ns | ns | ns | 0.002 | ns |
| 0.015 | 0.006 | 0.017 | 0.002 | <0.001 | 0.005 | 0.017 | 0.024 | ns | |
| ns | ns | ns | ns | <0.001 | 0.047 | ns | ns | ns | |
| RESP | ns | ns | ns | ns | <0.001 | 0.005 | ns | ns | 0.020 |
| GLU | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| PHO | ns | ns | ns | ns | 0.047 | ns | ns | ns | ns |
| LEU | ns | ns | ns | ns | ns | ns | ns | ns | ns |
| 16S rRNA | ns | ns | ns | ns | 0.016 | ns | ns | ns | ns |
| 18S rRNA | ns | 0.002 | ns | ns | ns | ns | ns | ns | ns |